Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-flow nasal cannula for Acute Respiratory Distress Syndrome (ARDS) due to COVID-19.

Multidisciplinary respiratory medicine·2020
Same author

The authors reply.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·2017
Same author

Acetazolamide Therapy for Metabolic Alkalosis in Pediatric Intensive Care Patients.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·2016
Same author

Citrate anticoagulation for CRRT in children: comparison with heparin.

BioMed research international·2014
Same author

Postoperative neutrophil gelatinase-associated lipocalin predicts acute kidney injury after pediatric cardiac surgery*.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·2013
Same author

Cross-sectional study of BK virus infection in pediatric kidney transplant recipients.

Pediatric transplantation·2007

Related Experiment Video

Updated: May 28, 2026

Intrarenal Injection of Escherichia coli in a Rat Model of Pyelonephritis
06:09

Intrarenal Injection of Escherichia coli in a Rat Model of Pyelonephritis

Published on: July 18, 2017

Electrolyte disturbances in acute pyelonephritis.

Maite Augusta Gil-Ruiz1, Andrés José Alcaraz, Rafael José Marañón

  • 1Pediatric Emergency Department, Gregorio Marañón University General Hospital, Madrid, Spain. maitegilr@gmail.com

Pediatric Nephrology (Berlin, Germany)
|October 11, 2011
PubMed
Summary

Infants with acute pyelonephritis may show renal unresponsiveness to aldosterone, leading to hyperkalemia. This condition, characterized by inadequate renal potassium excretion, is linked to inflammation and infant kidney immaturity.

More Related Videos

Establishment and Characterization of UTI and CAUTI in a Mouse Model
08:40

Establishment and Characterization of UTI and CAUTI in a Mouse Model

Published on: June 23, 2015

Related Experiment Videos

Last Updated: May 28, 2026

Intrarenal Injection of Escherichia coli in a Rat Model of Pyelonephritis
06:09

Intrarenal Injection of Escherichia coli in a Rat Model of Pyelonephritis

Published on: July 18, 2017

Establishment and Characterization of UTI and CAUTI in a Mouse Model
08:40

Establishment and Characterization of UTI and CAUTI in a Mouse Model

Published on: June 23, 2015

Area of Science:

  • Pediatric Nephrology
  • Infectious Diseases
  • Endocrinology

Background:

  • Acute pyelonephritis (APN) is a common kidney infection in infants.
  • Aldosterone is crucial for regulating potassium balance in the kidneys.
  • Infant kidneys have immature tubular function, potentially affecting electrolyte regulation.

Purpose of the Study:

  • To investigate renal unresponsiveness to aldosterone in infants with APN.
  • To identify clinical characteristics of infants with inadequate renal potassium excretion.
  • To explore the role of inflammation and immaturity in this condition.

Main Methods:

  • Studied 113 infants with APN (fever >38°C, bacteriuria).
  • Compared electrolyte and renal tubular function tests with 75 febrile infants without bacteriuria.
  • Defined inadequate response by hyperkalemia and low transtubular potassium gradient (TTKG).

Main Results:

  • Infants with APN showed hyperkalemia (>5.5 mmol/L).
  • APN group had lower TTKG and higher fractional sodium excretion.
  • Younger infants with APN were more prone to inadequate renal response to hyperkalemia.

Conclusions:

  • Infants with APN can exhibit renal unresponsiveness to aldosterone, causing hyperkalemia.
  • Renal interstitial inflammation and infant kidney immaturity likely contribute to this altered response.
  • This occurs even without urinary tract anomalies or obstruction.